Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,110
Closed -$742K 132
2026
Q1
$742K Buy
+2,110
New +$752K 0.03% 86
2025
Q4
Sell
-2,795
Closed -$789K 149
2025
Q3
$789K Buy
+2,795
New +$811K 0.04% 124
2023
Q2
Sell
-612
Closed -$148K 92
2023
Q1
$148K Buy
612
+498
+437% +$122K 0.01% 92
2022
Q4
$30K Buy
114
+4
+4% +$1.07K ﹤0.01% 148
2022
Q3
$25K Hold
110
﹤0.01% 143
2022
Q2
$27K Sell
110
-40
-27% -$9.8K ﹤0.01% 178
2022
Q1
$36K Sell
150
-40
-21% -$9.19K ﹤0.01% 109
2021
Q4
$43K Hold
190
﹤0.01% 113
2021
Q3
$40K Sell
190
-1,488
-89% -$342K ﹤0.01% 217
2021
Q2
$409K Buy
1,678
+1,268
+309% +$312K 0.03% 78
2021
Q1
$102K Sell
410
-59
-13% -$14.1K 0.01% 115
2020
Q4
$108K Buy
469
+214
+84% +$49.3K 0.01% 78
2020
Q3
$65K Buy
255
+74
+41% +$18.3K 0.01% 76
2020
Q2
$43K Buy
181
+6
+3% +$1.37K ﹤0.01% 79
2020
Q1
$35K Hold
175
﹤0.01% 87
2019
Q4
$42K Buy
+175
New +$38.6K ﹤0.01% 98
2019
Q3
Sell
-78
Closed -$14K 171
2019
Q2
$14K Sell
78
-454
-85% -$81.3K ﹤0.01% 144
2019
Q1
$101K Buy
532
+527
+10,540% +$101K 0.01% 48
2018
Q4
$1K Sell
5
-181
-97% -$35.3K ﹤0.01% 128
2018
Q3
$39K Buy
+186
New +$36.7K 0.01% 105
2015
Q1
Sell
-2,785
Closed -$444K 40
2014
Q4
$444K Buy
+2,785
New +$434K 0.14% 59

Other funds holding AMGN

Sageworth Trust's AMGN Position: Q2 2026 in Review

Sageworth Trust sold out of Amgen (AMGN) in Q2 2026, closing a stake of 2,110 shares — an estimated $742K sold.

Sageworth Trust first reported a position in AMGN in Q4 2014 and held it in 21 quarters. The position peaked at $789K in Q3 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sageworth Trust reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Sageworth Trust sold 2,110 Amgen shares in Q2 2026, an estimated $742K.
  • Sageworth Trust first reported a position in Amgen in Q4 2014 and held it in 21 quarters.
  • Sageworth Trust's Amgen position peaked at $789K in Q3 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sageworth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.